AdjuTec Pharma’s CEO: “Our goal is to set a new standard in antibiotic treatment”
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Nyhet

AdjuTec Pharma’s CEO: “Our goal is to set a new standard in antibiotic treatment”

AdjuTec Pharma’s CEO: “Our goal is to set a new standard in antibiotic treatment”

Late last year, AdjuTec Pharma launched a phase I clinical trial for its lead candidate, APC148, targeting antimicrobial resistance, AMR.

Recently, seasoned life science executive Jethro Holter stepped into the CEO role.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

Denna källa har få eller inga artiklar bakom betalvägg
Läs hela artikeln hos Biostock

Nyhetsbrev